Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to -$35.6 million.

  • Abeona Therapeutics' Consolidated Net Income fell 1747.33% to -$35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.8 million, marking a year-over-year increase of 16761.36%. This contributed to the annual value of -$68.4 million for FY2024, which is 4387.95% down from last year.
  • Per Abeona Therapeutics' latest filing, its Consolidated Net Income stood at -$35.6 million for Q3 2025, which was down 1747.33% from $108.8 million recorded in Q2 2025.
  • Over the past 5 years, Abeona Therapeutics' Consolidated Net Income peaked at $108.8 million during Q2 2025, and registered a low of -$46.7 million during Q4 2021.
  • In the last 5 years, Abeona Therapeutics' Consolidated Net Income had a median value of -$15.2 million in 2021 and averaged -$10.3 million.
  • As far as peak fluctuations go, Abeona Therapeutics' Consolidated Net Income tumbled by 19485.09% in 2021, and later skyrocketed by 136952.47% in 2025.
  • Over the past 5 years, Abeona Therapeutics' Consolidated Net Income (Quarter) stood at -$46.7 million in 2021, then soared by 71.9% to -$13.1 million in 2022, then fell by 1.56% to -$13.3 million in 2023, then crashed by 33.31% to -$17.8 million in 2024, then crashed by 100.28% to -$35.6 million in 2025.
  • Its Consolidated Net Income was -$35.6 million in Q3 2025, compared to $108.8 million in Q2 2025 and -$20.7 million in Q1 2025.